The Effects of Diet and Exercise Interventions in Peripheral Artery Disease
Part of paid clinical trials in Oklahoma City, Oklahoma.
- Sponsor
- University of Oklahoma
- Study ID
- NCT03845036
- Status
- Recruiting
Conditions
- Claudication
- Peripheral Artery Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- DASH Diet plus Home-Based Exercise — BEHAVIORALThe DASH dietary program consists of a diet emphasizing foods rich in fruits, vegetables, whole grains, and low-fat dairy, in which patients record daily servings of fruits and vegetables. The home-based exercise program consists of intermittent walking to moderate claudication pain 3 times per week for 3 months in a home-based setting.
- Home-Based Exercise — BEHAVIORALThe home-based exercise program consists of intermittent walking to moderate claudication pain 3 times per week for 3 months in a home-based setting.
Study Details
This study is a 3-month, prospective, randomized controlled clinical trial designed to address the efficacy of the DASH dietary program combined with a home-based exercise program, quantified by a step activity monitor, to improve exercise and vascular outcome measures in patients with PAD.
Key Dates
- Start date
- Sep 16, 2024
- Status verified
- Apr 2026
- Primary completion
- May 31, 2029
- Completion
- May 31, 2029
Study Design
- Enrollment
- 150 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: DASH Diet plus Home-Based ExerciseThe DASH dietary program consists of a diet emphasizing foods rich in fruits, vegetables, whole grains, and low-fat dairy, in which patients record daily servings of fruits and vegetables. The home-based exercise program consists of intermittent walking to moderate claudication pain 3 times per week for 3 months in a home-based setting.
- Active Comparator: Home-Based ExerciseThe home-based exercise program consists of intermittent walking to moderate claudication pain 3 times per week for 3 months in a home-based setting.
Primary Outcome Measure
Peak Walking Time [ Time Frame: 3 months ]
Central Contacts
- Andrew Gardner, Ph.D.405-271-4742
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| O'Donoghue Research Building, University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73117 |
Find similar trials in Oklahoma City, OK
By condition
By specialty
Related Studies
- The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery DiseaseRecruiting · University of Oklahoma · Oklahoma City, Oklahoma
- The THOR IDE StudyRecruiting · Philips Clinical & Medical Affairs Global · St. Helena, California
- Red Light Treatment in Peripheral Artery DiseaseRecruiting · University of Alabama at Birmingham · Milwaukee, Wisconsin
- Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial DiseaseRecruiting · Nationwide Children's Hospital · Columbus, Ohio